Dengue Fever

What it is

Dengue fever is a mosquito-borne viral illness that causes an estimated 100–400 million infections worldwide each year. It is caused by dengue virus, which is spread mainly by Aedes aegypti and Aedes albopictus mosquitoes, and it is common in tropical and subtropical regions. WHO notes that about half of the world's population now lives in areas at risk. In India, dengue is a major seasonal public health problem, especially during and after the monsoon, when mosquito breeding increases in urban and semi-urban settings.

Dengue is sometimes called "breakbone fever" because it can cause intense muscle and joint pain. Many infections are asymptomatic or mild, but some progress to severe dengue, which can lead to plasma leakage, bleeding, shock, organ dysfunction, and death if not recognized early. Symptoms usually begin 4 to 10 days after a mosquito bite and often last 2 to 7 days.

Common symptoms include:

• high fever
• severe headache
• pain behind the eyes
• muscle and joint pain
• nausea or vomiting
• rash
• tiredness

A second dengue infection with a different dengue virus serotype can increase the risk of severe disease.

How it works

Dengue virus belongs to the flavivirus family and has 4 main serotypes: DENV-1, DENV-2, DENV-3, and DENV-4. Infection with one serotype usually gives long-term protection against that same serotype, but not full protection against the others.

A simplified comparison is helpful:

Feature	Dengue
Cause	Dengue virus (4 serotypes)
Spread	Bite of infected Aedes mosquitoes
Typical incubation	About 4-10 days
Usual course	Fever illness lasting about 2-7 days
Severe form	Plasma leakage, bleeding, shock, organ injury

After the virus enters the body, it infects immune and other cells and triggers inflammation. In many people, this causes a self-limited fever illness. In some, especially during a later infection with a different serotype, immune responses may contribute to capillary leak and a sudden worsening around the time the fever starts settling. This is why a patient can seem to improve and then become more unwell during the so-called critical phase.

The dangerous part of dengue is often not the fever itself but the body's response, which can reduce circulating blood volume and impair blood flow to organs. Platelet counts often fall, but bleeding risk depends on more than the platelet number alone.

Diagnosis / how it's measured

Doctors diagnose dengue using symptoms, travel or local exposure history, physical examination, and laboratory testing. The timing of the test matters.

Common diagnostic approaches include:

1. Early illness, usually first week: viral detection tests such as NAAT/PCR or NS1 antigen tests may be useful.
2. Later illness: antibody tests such as IgM or paired serology may help.
3. Monitoring severity: complete blood count, platelet count, hematocrit, liver tests, and fluid status are often followed.

Typical lab patterns can include:

• low platelet count
• low white blood cell count
• rising hematocrit if plasma leakage occurs
• mild to moderate liver enzyme elevation

Warning signs that raise concern for severe dengue include:

• severe abdominal pain
• persistent vomiting
• bleeding from gums or nose
• lethargy or restlessness
• rapid breathing
• blood in vomit or stool
• pale, cold, clammy skin
• reduced urine output

A low platelet count alone does not define severe dengue. Clinicians look at the whole picture, especially evidence of plasma leakage, shock, bleeding, or organ involvement.

Evidence and uses

There is no specific antiviral treatment routinely used for most dengue infections. Management is mainly supportive, and early recognition of warning signs is one of the most important factors in preventing death.

Supportive care may include:

• oral fluids for mild illness
• careful intravenous fluids when dehydration or plasma leakage is present
• paracetamol (acetaminophen) for fever and pain
• monitoring for shock, bleeding, and organ dysfunction

Most people recover within 1 to 2 weeks. Severe dengue usually requires hospital care, sometimes with close hemodynamic monitoring. WHO emphasizes that early detection and proper medical care can greatly lower fatality from severe dengue.

Prevention focuses on avoiding mosquito bites and reducing mosquito breeding sites. Measures include covering water containers, removing standing water, using window screens, wearing long sleeves, and using mosquito repellents. Because Aedes mosquitoes often bite during the day, daytime bite prevention matters.

Vaccines for dengue exist in some settings, but their use depends on the product, local policy, age group, and whether a person has had prior dengue infection. Vaccine recommendations are not the same for every country or every patient, so readers should follow local public health guidance.

When to see a clinician

Anyone with suspected dengue should seek medical advice if they have high fever plus severe body pain, rash, vomiting, or live in or recently traveled to an area with dengue transmission. In India and other endemic regions, testing may be considered during seasonal outbreaks even when symptoms overlap with chikungunya, malaria, typhoid, or viral fever.

Seek urgent care immediately if any warning sign appears, especially near the time fever is coming down. The highest-risk period for severe dengue is often around defervescence, not necessarily at the peak of fever.

Get urgent medical help for:

• severe abdominal pain
• repeated vomiting
• fainting or extreme weakness
• bleeding
• difficulty breathing
• confusion
• inability to drink fluids
• very little urine

Children, pregnant patients, older adults, and people with chronic illness may need closer monitoring.

Limitations and open questions

Dengue can be hard to distinguish from other febrile illnesses early in the course, especially in places where malaria, chikungunya, Zika, leptospirosis, or enteric fever also occur. Test performance varies by timing, method, and local laboratory quality, so a negative early test does not always rule dengue out.

Research continues on why some people develop severe dengue while others do not. Prior infection with a different serotype is one factor, but age, viral strain, host genetics, and underlying health conditions also appear to matter. Evidence is also evolving on the best use of vaccines across different populations and transmission settings.

There is no proven home remedy, supplement, or herbal product that reliably treats dengue or raises platelets in a clinically meaningful way. Claims about papaya leaf extract and similar products remain mixed, with limited and inconsistent human evidence and no replacement for medical monitoring. People should avoid self-medicating with aspirin, ibuprofen, or other NSAIDs unless a clinician specifically advises otherwise, because these drugs can increase bleeding risk. If dengue is suspected, it is safest to discuss medicines with a clinician or pharmacist.